the Effects of Perioperative Goal Directed and Conventional Fluid Management on the IVC Collapsibility Index
Comparison of the Effects of Perioperative Targeted and Traditional Fluid Management on Inferior Vena Cava Collapsibility Index and Postoperative Complications in Geriatric Patients Undergoing Proximal Femoral Surgery
1 other identifier
interventional
60
1 country
1
Brief Summary
The investigators aimed to compare the effects of targeted fluid management and traditional fluid management on the inferior vena cava collapsibility index in participants who will undergo proximal femoral surgery. In addition, the amount of fluid given, blood products, the number of perioperative hypotensive events, perioperative hemodynamics, perioperative and postoperative blood gas analysis, perioperative urine output and bleeding amount, postoperative complications (cardiac, respiratory, renal, etc.), postoperative 30-day mortality, nausea and vomiting score, It was aimed to evaluate and compare the postoperative hospitalization day as secondary.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2021
CompletedFirst Submitted
Initial submission to the registry
November 16, 2021
CompletedFirst Posted
Study publicly available on registry
December 13, 2021
CompletedDecember 13, 2021
November 1, 2021
3 months
November 16, 2021
November 29, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Inferior vena cava (IVC) collapsibility index
inspiratory IVC diameter and expiratory IVC diameter will measured and collapsibility index will be calculated
one month
Secondary Outcomes (4)
amount of given crystalloid and colloid volume
one month
arterial blood gas analysis
one month
postoperative complications (yes or no)
one month
postoperative 30-day mortality (yes or no)
one month
Study Arms (2)
Grup HYT
ACTIVE COMPARATORThe group (GRUP HYT) to be treated with targeted fluid therapy will be monitored with a Mostcaretm (Vygon, VytechHealth, Padova, Italy) pulse contour hemodynamic monitor after arterial cannulation. Cardiacindex (CI), stroke volume variance (SVV), pulse pressure variance (PPV), systemic vascular resistance (SVR), systemic vascular resistance index (SVRI), oxygen delivery (Do2), arterial elastance (Ea) measurements and mean arterial pressure Every 5 minutes to be followed, fluid therapy will be planned in accordance with our algorithm.
Grup KON
NO INTERVENTIONFluid deficit due to fasting time will be calculated in accordance with the 4-2-1 rule for patients in Group KON. half of the calculated fluid volume in the first hour; the remaining half will be given at the 2nd and 3rd Hours. (4ml/kg/hr for the first 10 kilograms, 2ml/kg/hr for the second 10 kg, 1ml/kg/hr for each subsequent kilogram). Maintenance fluid will be considered as a medium-sized surgical trauma and will be given at 4 ml/kg/hr. Hemorrhages will be replaced with 3 times the blood loss with balanced crystalloid or 1 times HES.
Interventions
mostcare hemodynamic monitoring integrated into the radial artery catheter. According to the data obtained, intraoperative fluid management was arranged with certain algorithms.
Eligibility Criteria
You may qualify if:
- years and older
- ASA anesthesia risk
- Planned to undergo proximal femoral surgery due to intertochanteric fracture
You may not qualify if:
- cardiac arrhythmia,
- chronic renal failure and those on dialysis,
- heart failure,
- aortic insufficiency,
- active lower/upper respiratory tract infections,
- inferior vena cava cannot be clearly visualized by USG, BMI\>35, Patients in need of postoperative intensive care or ASA4, Patients with advanced obstructive or restrictive respiratory diseases, Patients under 65 years of age.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fatih Sultan Mehmet Research and Training Hospital
Istanbul, 34752, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
arzu yıldırım ar, ass prof
Fatih Sultan Mehmet Training and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Masking Details
- The patients who accepted to participate in the study and the doctor who measured the inferior vena cava did not know the groups of the patients.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 16, 2021
First Posted
December 13, 2021
Study Start
July 1, 2021
Primary Completion
October 1, 2021
Study Completion
October 15, 2021
Last Updated
December 13, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will share